| Reducing
diastolic blood pressure to below 90 mmHg in patients with hypertension but without
diabetes may not provide any benefits, according to an analysis of various studies
reported in the Australian Prescriber.
Suzanne Hill,
of the University of Newcastle in Australia, analyzed several
hypertension studies. She found that only one -- the Hypertension
Optimal Treatment (HOT) study -- examined the effect of lowering
blood pressure to different targets in patients with or without
diabetes.
According
to Hill, the HOT study showed the benefits of lowering diastolic blood pressure
to 82.6 mmHg and implied that the targets for the treatment of hypertension should
be lower than the previously accepted mark of 90 mmHg.
But Hill said
the HOT study does not provide sufficient evidence of the benefits
of intensive treatment of blood pressure to reduce diastolic pressure
below 90 mmHg in patients with hypertension, but without diabetes.
Hill added
that the study did find that patients with diabetes in the lowest
target blood pressure group had significantly lower rates of cardiovascular
events and decreased mortality.
"This
highlights
the need to consider hypertension in the context of the other risk factors that
an individual patients possesses," said Hill. "Just lowering blood pressure
to an arbitrary target, particularly in a low-risk patient, may not provide benefits
and may cause harm." Hill
said one size rarely fits all for hypertensive patients without multiple risk
factors for cardiovascular disease. "And a single target blood pressure for
the treatment of hypertension across all patients groups is clearly not justified,"
she observed. Other
sources: Australian Prescriber (2003:26:53-5)
|